Doctor-pharma nexus: 'Govt mulling to introduce new code'

Image
Press Trust of India New Delhi
Last Updated : Jan 25 2013 | 4:04 AM IST

Health Minister Ghulam Nabi Azad, in his written reply to a question in the House, said his Ministry had received 702 complaints against doctors regarding their alleged nexus with drug manufacturers.

The complaints have been referred to the Medical Council of India (MCI) for action, he said.

"The government proposes to make the existing provisions more stringent through 'Uniform Code of Pharmaceutical Marketing Practices' (UCPMP) proposed by the Department of Pharmaceuticals," Azad said in his written reply.

He said a total of 702 such complaints against doctors have been received by the MCI in 2011-12, of which 343 have been referred to state Medical Councils/governments, while registration of three doctors has been temporarily suspended and one doctor has been given a warning and 168 cases are under consideration of the MCI.

In 2010-11, Azad said, a total of 824 complaints were received and 468 were referred to State Medical Councils/ governments while registration of 10 doctors was suspended temporarily and warnings issued to four doctors.

Similarly, 769 complaints against doctors were received by MCI in 2009-10 and registration of 16 doctors was suspended temporarily and warnings issued to six doctors, while remaining 254 cases were referred to states.

Azad said MCI takes action in such complaints as per provisions of the Indian Medical Council (Professional conduct, Etiquette and Ethics) Regulations, 2002.

  

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 17 2012 | 6:20 PM IST

Next Story